Annette S Gross

9PUBLICATIONS
21CO-AUTHORS
PharmacogenomicsMolecular targetsCell physiologyHaematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Dec 26, 2025
Pharmacokinetics of pazopanib: a review of the determinants, influencing factors and the clinical importance of therapeutic drug monitoring.

Nicki M Kyriacou, Annette S Gross, Andrew J McLachlan

|Apr 29, 2025
Inter-Ethnic Differences in the Efficacy and Safety of Tyrosine Kinase Inhibitors Used in Oncology: Insights From Phase 3 Clinical Trials.

Nicki M Kyriacou, Annette S Gross, Andrew J McLachlan

|Jul 07, 2023
Application of physiologically based pharmacokinetic modeling to understand real-world outcomes in patients receiving imatinib for chronic myeloid leukemia.

Josephine A Adattini, Jeffry Adiwidjaja, Annette S Gross

|Sep 15, 2022
Real-world efficacy and safety outcomes of imatinib treatment in patients with chronic myeloid leukemia: An Australian experience.

Josephine A Adattini, Annette S Gross, Nicole Wong Doo

|Jan 28, 2022
Clinical trial diversity: An opportunity for improved insight into the determinants of variability in drug response.

Annette S Gross, Anya C Harry, Christine S Clifton

Pageof 2